MILLENNIUM MANAGEMENT LLC - NEOLEUKIN THERAPEUTICS INC ownership

NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 87 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of NEOLEUKIN THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$506,010
+92916.5%
609,651
-21.6%
0.00%
Q1 2023$544
-32.7%
777,148
-51.0%
0.00%
Q4 2022$808
-99.9%
1,587,267
-6.4%
0.00%
-100.0%
Q3 2022$1,085,000
-50.2%
1,695,383
-19.9%
0.00%0.0%
Q2 2022$2,180,000
-6.2%
2,116,143
+71.2%
0.00%0.0%
Q1 2022$2,323,000
-46.7%
1,235,707
+36.7%
0.00%
-50.0%
Q4 2021$4,356,000
+114.8%
903,660
+222.1%
0.00%
+100.0%
Q3 2021$2,028,000
+39.1%
280,517
+77.6%
0.00%0.0%
Q2 2021$1,458,000
-19.1%
157,971
+7.9%
0.00%0.0%
Q1 2021$1,802,000
-10.6%
146,349
+2.4%
0.00%0.0%
Q4 2020$2,015,000
+152.2%
142,898
+114.7%
0.00%0.0%
Q3 2020$799,000
-76.1%
66,565
-67.0%
0.00%
-80.0%
Q2 2020$3,348,000
-60.9%
201,671
-73.2%
0.01%
-73.7%
Q1 2020$8,568,000
+1359.6%
752,941
+1480.3%
0.02%
+1800.0%
Q4 2019$587,000
-49.7%
47,644
-88.4%
0.00%
-50.0%
Q3 2019$1,166,000409,2030.00%
Other shareholders
NEOLEUKIN THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Lynx1 Capital Management LP 2,291,133$1,166,1871.01%
Privium Fund Management (UK) Ltd 117,200$59,6550.04%
Redmile Group, LLC 1,850,566$941,9380.04%
Baker Brothers Advisors 3,821,740$1,945,2660.01%
Kynam Capital Management, LP 120,764$61,4690.01%
Sio Capital Management, LLC 38,312$19,5010.01%
SIMON QUICK ADVISORS, LLC 46,856$23,8500.00%
Tri Locum Partners LP 10,248$5,0000.00%
Endurance Wealth Management, Inc. 20,000$100.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 75,000$38,1750.00%
View complete list of NEOLEUKIN THERAPEUTICS INC shareholders